TTC36
gene geneOn this page
Also known as HBP21
Summary
TTC36 (tetratricopeptide repeat domain 36, HGNC:33708) is a protein-coding gene on chromosome 11q23.3, encoding Tetratricopeptide repeat protein 36 (A6NLP5).
The protein encoded by this gene has three tetratricopeptide repeats and is a chaperone for heat shock protein 70. The encoded protein may function as a tumor suppressor in hepatocellular carcinoma (HCC) since it promotes apoptosis but is downregulated in HCC.
Source: NCBI Gene 143941 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 25 total
- MANE Select transcript:
NM_001080441
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:33708 |
| Approved symbol | TTC36 |
| Name | tetratricopeptide repeat domain 36 |
| Location | 11q23.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | HBP21 |
| Ensembl gene | ENSG00000172425 |
| Ensembl biotype | protein_coding |
| OMIM | 620701 |
| Entrez | 143941 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 4 protein_coding, 2 nonsense_mediated_decay
ENST00000302783, ENST00000528570, ENST00000533501, ENST00000909208, ENST00000909209, ENST00000909210
RefSeq mRNA: 3 — MANE Select: NM_001080441
NM_001080441, NM_001346096, NM_001346097
CCDS: CCDS31687
Canonical transcript exons
ENST00000302783 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003495646 | 118528603 | 118528791 |
| ENSE00003547151 | 118530654 | 118530993 |
| ENSE00003891219 | 118527474 | 118527612 |
Expression profiles
Bgee: expression breadth ubiquitous, 128 present calls, max score 97.65.
FANTOM5 (CAGE): breadth broad, TPM avg 0.8658 / max 185.2223, expressed in 319 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 117008 | 0.5440 | 278 |
| 117006 | 0.2585 | 28 |
| 117007 | 0.0378 | 6 |
| 117005 | 0.0201 | 6 |
| 117004 | 0.0053 | 3 |
Top tissues by expression
132 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right lobe of liver | UBERON:0001114 | 97.65 | gold quality |
| liver | UBERON:0002107 | 96.53 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 79.64 | gold quality |
| duodenum | UBERON:0002114 | 78.70 | gold quality |
| kidney | UBERON:0002113 | 74.52 | gold quality |
| cortex of kidney | UBERON:0001225 | 70.82 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 69.20 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 68.84 | gold quality |
| small intestine | UBERON:0002108 | 68.59 | gold quality |
| cortical plate | UBERON:0005343 | 66.83 | gold quality |
| metanephros cortex | UBERON:0010533 | 66.50 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 66.23 | gold quality |
| gastrocnemius | UBERON:0001388 | 66.16 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 66.06 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 65.50 | gold quality |
| muscle of leg | UBERON:0001383 | 65.46 | gold quality |
| cerebellum | UBERON:0002037 | 65.28 | gold quality |
| cerebellar cortex | UBERON:0002129 | 65.16 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 65.15 | gold quality |
| pituitary gland | UBERON:0000007 | 64.71 | gold quality |
| adipose tissue | UBERON:0001013 | 64.55 | gold quality |
| left adrenal gland | UBERON:0001234 | 64.35 | gold quality |
| ganglionic eminence | UBERON:0004023 | 64.18 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 63.99 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 63.81 | gold quality |
| apex of heart | UBERON:0002098 | 63.24 | gold quality |
| right adrenal gland | UBERON:0001233 | 63.20 | gold quality |
| omental fat pad | UBERON:0010414 | 62.96 | gold quality |
| heart left ventricle | UBERON:0002084 | 62.88 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 62.88 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-HCAD-38 | yes | 486.23 |
| E-ANND-3 | yes | 8.20 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 3)
- The newly discovered interaction between HBP21 and Hsp70 suggests that HBP21 may be involved in the inhibition of progression and metastasis of tumor cells. (PMID:18587674)
- As a chaperone of heat shock protein 70 (HSP70), HBP21 could inhibit interaction between HSP70 and Bax, increased Bax protein translocation from cytoplasm to mitochondria. (PMID:26246424)
- Heat Shock-Binding Protein 21 Regulates the Innate Immune Response to Viral Infection. (PMID:35254105)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ttc36 | ENSDARG00000011693 |
| mus_musculus | Ttc36 | ENSMUSG00000039438 |
| rattus_norvegicus | Ttc36 | ENSRNOG00000075307 |
| drosophila_melanogaster | CG14105 | FBGN0036359 |
| caenorhabditis_elegans | WBGENE00009947 |
Protein
Protein identifiers
Tetratricopeptide repeat protein 36 — A6NLP5 (reviewed: A6NLP5)
Alternative names: HSP70-binding protein 21
All UniProt accessions (2): A6NLP5, E9PNF0
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the TTC36 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| A6NLP5-1 | 1 | yes |
| A6NLP5-2 | 2 |
RefSeq proteins (3): NP_001073910, NP_001333025, NP_001333026 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR011990 | TPR-like_helical_dom_sf | Homologous_superfamily |
| IPR019734 | TPR_rpt | Repeat |
| IPR038906 | TTC36 | Family |
Pfam: PF13424
UniProt features (6 total): repeat 3, chain 1, splice variant 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6NLP5-F1 | 85.71 | 0.58 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 94 (showing top):
GSE45365_NK_CELL_VS_CD11B_DC_UP, GOBP_MEMORY, GOBP_NEGATIVE_REGULATION_OF_PROTEOLYSIS, GOBP_REGULATION_OF_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS, GOBP_COGNITION, GOBP_BEHAVIOR, GOBP_REGULATION_OF_PHOSPHORYLATION, GOBP_ALPHA_AMINO_ACID_METABOLIC_PROCESS, GOBP_ASSOCIATIVE_LEARNING, GOBP_MACROMOLECULE_CATABOLIC_PROCESS, GOBP_NEUROGENESIS, GOBP_NEGATIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS, GOBP_REGULATION_OF_CATABOLIC_PROCESS, GOBP_AROMATIC_AMINO_ACID_METABOLIC_PROCESS, GOBP_LEARNING
GO Biological Process (6): obsolete tyrosine metabolic process (GO:0006570), memory (GO:0007613), visual learning (GO:0008542), central nervous system neuron development (GO:0021954), negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435), negative regulation of protein polyubiquitination (GO:1902915)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| learning or memory | 1 |
| visual behavior | 1 |
| associative learning | 1 |
| central nervous system neuron differentiation | 1 |
| neuron development | 1 |
| regulation of proteasomal ubiquitin-dependent protein catabolic process | 1 |
| proteasome-mediated ubiquitin-dependent protein catabolic process | 1 |
| negative regulation of proteasomal protein catabolic process | 1 |
| negative regulation of ubiquitin-dependent protein catabolic process | 1 |
| protein polyubiquitination | 1 |
| negative regulation of protein ubiquitination | 1 |
| regulation of protein polyubiquitination | 1 |
| binding | 1 |
Protein interactions and networks
STRING
538 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TTC36 | HSPA4 | P34932 | 508 |
| TTC36 | STK33 | Q9BYT3 | 472 |
| TTC36 | RNF138 | Q8WVD3 | 446 |
| TTC36 | TMEM74B | Q9NUR3 | 433 |
| TTC36 | SRCIN1 | Q9C0H9 | 422 |
| TTC36 | GCC2 | Q8IWJ2 | 418 |
| TTC36 | TTC38 | Q5R3I4 | 416 |
| TTC36 | FAH | P16930 | 415 |
| TTC36 | TMEM182 | Q6ZP80 | 397 |
| TTC36 | PI4K2A | Q9BTU6 | 385 |
| TTC36 | TTC9C | Q8N5M4 | 367 |
| TTC36 | PELI1 | Q96FA3 | 362 |
| TTC36 | SMIM24 | O75264 | 343 |
| TTC36 | ZNF665 | Q9H7R5 | 323 |
| TTC36 | SPDYC | Q5MJ68 | 322 |
IntAct
0 interactions, top by confidence:
BioGRID (3): TTC36 (Affinity Capture-MS), HPD (Affinity Capture-Western), TTC36 (Reconstituted Complex)
ESM2 similar proteins: A0A1D5PJB7, A1A4Q9, A5YM72, A6NLP5, D3KCC4, I3L5V6, O43292, P10938, Q00973, Q05B52, Q09200, Q10468, Q14623, Q148G5, Q16586, Q2V8X7, Q3SZV0, Q561R2, Q5E9M9, Q5M868, Q5ZL13, Q66H45, Q69ZF3, Q6P3D0, Q6P7A1, Q6P9Z4, Q6SZW1, Q6TEC1, Q6ZPS2, Q7TMC8, Q864R5, Q86TX2, Q8IXI1, Q8N0W3, Q8N3Y3, Q8N6R0, Q8NF37, Q8NI29, Q8TCD5, Q8VBW8
Diamond homologs: A6NLP5, A7RL75, A8E7I5, A8XHX1, Q20683, Q2M021, Q3SZV0, Q5EBF2, Q66H45, Q8VBW8, Q9VU70, Q57992, O16259, Q12118, Q5U2X2, O13797
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| TTC36 | “up-regulates quantity by stabilization” | HPD | binding |
Disease & clinical
Clinical variants and AI predictions
ClinVar
25 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 23 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
389 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:118527585:G:GT | donor_gain | 1.0000 |
| 11:118527597:G:GT | donor_gain | 1.0000 |
| 11:118527609:GAAG:G | donor_gain | 1.0000 |
| 11:118527609:GAAGG:G | donor_loss | 1.0000 |
| 11:118527610:AAGG:A | donor_loss | 1.0000 |
| 11:118527611:AGGT:A | donor_loss | 1.0000 |
| 11:118527613:G:GC | donor_loss | 1.0000 |
| 11:118527614:T:A | donor_loss | 1.0000 |
| 11:118530643:C:A | acceptor_gain | 1.0000 |
| 11:118527610:A:T | donor_gain | 0.9900 |
| 11:118528560:C:G | acceptor_gain | 0.9900 |
| 11:118528562:A:AG | acceptor_gain | 0.9900 |
| 11:118528562:AACT:A | acceptor_gain | 0.9900 |
| 11:118528565:T:A | acceptor_gain | 0.9900 |
| 11:118528583:T:TA | acceptor_gain | 0.9900 |
| 11:118528595:T:TA | acceptor_gain | 0.9900 |
| 11:118528789:CAGGT:C | donor_loss | 0.9900 |
| 11:118528790:AGGTA:A | donor_loss | 0.9900 |
| 11:118528791:GG:G | donor_loss | 0.9900 |
| 11:118528792:GTAA:G | donor_loss | 0.9900 |
| 11:118528793:T:G | donor_loss | 0.9900 |
| 11:118530652:A:AG | acceptor_gain | 0.9900 |
| 11:118530653:G:GG | acceptor_gain | 0.9900 |
| 11:118530653:GGC:G | acceptor_gain | 0.9900 |
| 11:118528555:T:TA | acceptor_gain | 0.9800 |
| 11:118528559:A:AG | acceptor_gain | 0.9800 |
| 11:118528563:A:G | acceptor_gain | 0.9800 |
| 11:118528570:ACCT:A | acceptor_gain | 0.9800 |
| 11:118530648:CCGCA:C | acceptor_loss | 0.9800 |
| 11:118530649:CGCA:C | acceptor_loss | 0.9800 |
AlphaMissense
1210 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:118528656:G:T | G58W | 0.981 |
| 11:118528668:G:C | A62P | 0.981 |
| 11:118530735:G:A | G130E | 0.979 |
| 11:118528656:G:A | G58R | 0.977 |
| 11:118528656:G:C | G58R | 0.977 |
| 11:118530806:A:C | S154R | 0.977 |
| 11:118530808:C:A | S154R | 0.977 |
| 11:118530808:C:G | S154R | 0.977 |
| 11:118528693:C:A | A70D | 0.976 |
| 11:118528758:G:C | A92P | 0.974 |
| 11:118528756:G:C | R91P | 0.973 |
| 11:118530719:A:C | S125R | 0.973 |
| 11:118530721:C:A | S125R | 0.973 |
| 11:118530721:C:G | S125R | 0.973 |
| 11:118528759:C:A | A92D | 0.972 |
| 11:118530858:G:A | C171Y | 0.971 |
| 11:118530859:C:G | C171W | 0.971 |
| 11:118530669:T:C | L108P | 0.970 |
| 11:118530734:G:A | G130R | 0.970 |
| 11:118530734:G:C | G130R | 0.970 |
| 11:118528657:G:A | G58E | 0.969 |
| 11:118528713:G:C | A77P | 0.968 |
| 11:118530677:G:C | A111P | 0.964 |
| 11:118528771:G:C | R96P | 0.961 |
| 11:118528751:C:A | N89K | 0.960 |
| 11:118528751:C:G | N89K | 0.960 |
| 11:118530732:G:C | R129P | 0.960 |
| 11:118530857:T:C | C171R | 0.960 |
| 11:118528764:G:C | A94P | 0.958 |
| 11:118530738:T:C | L131P | 0.958 |
dbSNP variants (sampled 300 via entrez): RS1000988402 (11:118525894 G>T), RS1001040546 (11:118525628 A>G), RS1001304418 (11:118528663 T>C,G), RS1001440013 (11:118528401 A>G), RS1002451007 (11:118526528 T>C), RS1002955641 (11:118529377 A>C), RS1003809407 (11:118526541 T>G), RS1003839161 (11:118527108 T>C), RS1005058299 (11:118531387 G>A), RS1005484447 (11:118528453 C>T), RS1007011506 (11:118529263 T>C), RS1007065452 (11:118528996 G>A), RS1010077208 (11:118528331 C>A), RS1010460216 (11:118528008 T>C), RS1010721417 (11:118530630 C>A,T)
Disease associations
OMIM: gene MIM:620701 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, decreases expression | 2 |
| ferrous chloride | decreases expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Aflatoxin B1 | decreases expression, decreases methylation | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.